MoonLake Immunotherapeutics (MLTX)
40.86
+0.17
(+0.42%)
USD |
NASDAQ |
May 16, 16:00
40.85
-0.01
(-0.02%)
After-Hours: 20:00
MoonLake Immunotherapeutics Cash and Short Term Investments (Quarterly): 547.05M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 547.05M |
| December 31, 2023 | 511.01M |
| September 30, 2023 | 495.98M |
| June 30, 2023 | 501.79M |
| March 31, 2023 | 63.05M |
| Date | Value |
|---|---|
| December 31, 2022 | 72.11M |
| September 30, 2022 | 83.46M |
| June 30, 2022 | 92.71M |
| December 31, 2021 | 8.039M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
8.039M
Minimum
Dec 2021
547.05M
Maximum
Mar 2024
263.91M
Average
92.71M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Qiagen NV | 893.13M |
| LENZ Therapeutics Inc | 213.28M |
| AC Immune SA | 116.17M |
| CRISPR Therapeutics AG | 2.108B |
| Addex Therapeutics Ltd | 4.603M |